Im just trying to be optimistic. This story has been updated to correct the number of MassHealth enrollees under 21 in the state prescribed GLP-1s solely for weight loss
GLP-1s improve systemic insulin sensitivity, reduce vascular inflammation, enhance endothelial function, and modestly lower blood pressure collectively improving blood flow and nutrient delivery to the brain [12]
As telehealth platforms, social media and algorithms reshape access, medical oversight may be taking a backseat, raising urgent ethical, legal and patient safety concerns
(Its also sold as Ozempic to treat type 2 diabetes.) Both drugs, made by Novo Nordisk, are injected weekly
Your physician will guide you through dose titration to minimize side effects
Novo Nordisk has launched the Medicare GLP-1 Bridge, making Wegovy available to eligible Medicare beneficiaries for $50 a month through the end of 2027, giving millions of older adults with obesity a structured pathway to the FDA-approved weight management drug
